Investment
Features
FeesSafety
Academy
More
Pluang+

Compare SPDR Gold Trust (GLD) vs Nuwellis Inc (NUWE) Price & Performance

SPDR Gold TrustTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

SPDR Gold Trust vs Nuwellis Inc — how do they compare? SPDR Gold Trust trades at $383.66 (market cap $139.66B), while Nuwellis Inc trades at $0.69 (market cap $2.20M). The key difference: SPDR Gold Trust is far larger — about 63481.8× Nuwellis Inc's market cap, and SPDR Gold Trust is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SPDR Gold Trust for 74 Days and Nuwellis Inc for 26 Days on average.

GLDNUWE
Market Cap
$139.66B$2.20M
Volume
9,544,773121,544
52-Week High
$495.90$146.65
52-Week Low
$362.32$0.68
Typical Hold Time
74 Days26 Days
Sector
—Health
Enterprise Value
—-$1.52M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SPDR Gold Trust

GLD is trading at $375.88, down 1.66% over the past 24 hours amid broader market pressure from rising Treasury yields and Federal Reserve policy uncertainty. The technical picture remains bearish with moving averages and oscillators signaling continued downward momentum, while key support levels cluster around $372-375. Recent news highlights gold's struggle to maintain gains despite weak economic data, with prices testing critical support zones.

The outlook for GLD remains challenged by persistent headwinds from elevated yields and dollar strength, though some analysts see tactical buying opportunities at current levels. Key risks include further Fed tightening and deteriorating technical momentum, while potential catalysts include sustained inflation concerns and geopolitical tensions that could revive safe-haven demand.

Nuwellis Inc

NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.

The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GLD
72% Buy28% Sell
Avg holding period · 74 Days
NUWE
40% Buy60% Sell
Avg holding period · 26 Days

Top news

Latest headlines on both assets

About SPDR Gold Trust

GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.

Read more on GLD →

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE →